Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
HRA Pharma
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Aged 18 years or more
Menstruating women with regular menstrual cycle between 24 and 35 days and intra-individual variations less than or equal to 5 days
Request emergency contraception between 48 hours and 120 hours after unprotected intercourse as defined by lack of contraceptive use, or condom breakage (including condoms lubricated with spermicide) or other barrier contraceptive method failure
No current use of hormonal contraception and having had at least one complete menstrual cycle (2 menses) since having stopped hormonal contraception
For women with a recent history of Depo Provera use, the most recent injection must have been at least 9 months before study entry and followed by at least one complete menstrual cycle (2 menses)
Willing to not use hormonal methods of contraception until study completion
At least one complete menstrual cycle (2 menses) post delivery, miscarriage or abortion
Able to provide informed consent in English
Give voluntary, written informed consent, and agree to observe all study requirements (the subject needs to be available for follow-up over the next 6 weeks)
Willing to abstain from further acts of unprotected intercourse during participation in the study and until pregnancy status has been ascertained
You may not be if
One or more acts of one unprotected intercourse more than 120 hours before requesting emergency contraception in the current cycle
All acts of unprotected intercourse (in the current cycle) within 48 hours of presentation
Currently pregnant as confirmed by positive HSUP test performed at screening
Currently breast-feeding
Current use of hormonal contraception
Use of hormonal emergency contraception since last menstrual period
Current use of IUD
Tubal ligation
Partner with a vasectomy
Unsure about the date of the last menstrual period
Severe asthma insufficiently controlled by oral glucocorticoid
Currently enrolled in any other trial of an investigational medicine
Clareo Health | Safety and Efficacy of CDB-2914 for Emergency Contraception
